We are rapidly demystifying cancers, exposing the molecular mechanisms underlying tumors and leading the search for the next generation of targeted cancer therapies. We see a future where every cancer and every patient has a cure.

Novel tool confers targeted, stable editing of epigenome in human stem cells

The lab of Juan Carlos Izpisua Belmonte has developed a novel technology to correct disease-causing aberrations in the chemical tags on DNA that affect how genes are expressed. These types of chemical modifications, collectively referred to as the epigenome, are increasingly being considered as important as the genome itself in development and disease. In the May 4, 2017, issue of Science the team described how they used the tool to model mutations in tags associated with colon cancer and to restore the proper tags in stem cells derived from people with Angelman syndrome.

Sign up for our monthly newsletter.

Latest discoveries, events & more.